Please login to the form below

Not currently logged in
Email:
Password:

Mavenclad

This page shows the latest Mavenclad news and features for those working in and with pharma, biotech and healthcare.

England opens new NHS ‘front door’ to health innovators

England opens new NHS ‘front door’ to health innovators

well as Merck’s multiple sclerosis drug Mavenclad.

Latest news

More from news
Approximately 3 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    The Accelerated Access Collaborative. Ewan Barbour, Market Access and Pricing Director, Merck, presented on its multiple sclerosis treatment Mavenclad being selected to be among the first designated Rapid Uptake products on ... Ewan Barbour. He said the

  • Pharma: in search of the sustainable ‘win win’ with the NHS Pharma: in search of the sustainable ‘win win’ with the NHS

    The company has just secured 'Rapid Uptake' status for its multiple sclerosis drug Mavenclad via the new Accelerated Access Collaborative process.

  • Tackling a formidable foe Tackling a formidable foe

    MAVENCLAD offers lasting control of the disease allowing them to plan for pregnancy once the treatment course is completed. ... MAVENCLAD’S short-course oral therapy profile is a bonus to a condition freighted with psychological drag-weights.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics